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Background: The treatment of tendon lesions with multipotent mesenchymal stromal cells (MSCs) is widely used
in equine medicine. Cell sources of MSCs include bone marrow, as well as solid tissues such as adipose tissue. MSCs
can be isolated from these solid tissues either by enzymatic digestion or by explant technique. However, the
different preparation techniques may potentially influence the properties of the isolated MSCs. Therefore, the aim of
this study was to investigate and compare the effects of these two different methods used to isolate MSCs from
solid tissues.
Equine adipose tissue, tendon and umbilical cord matrix served as solid tissue sources of MSCs with different
stiffness and density. Subsequent to tissue harvest, MSCs were isolated either by enzymatic digestion with
collagenase or by explant technique. Cell yield, growth, differentiation potential and tendon marker expression
were analysed.
Results: At first passage, the MSC yield was significantly higher in enzymatically digested tissue samples than in
explanted tissue samples, despite a shorter period of time in primary culture. Further analysis of cell proliferation,
migration and differentiation revealed no significant differences between MSCs isolated by enzymatic digestion and
MSCs isolated by explant technique. Interestingly, analysis of gene expression of tendon markers revealed a
significantly higher expression level of scleraxis in MSCs isolated by enzymatic digestion.
Conclusions: Both isolation techniques are feasible methods for successful isolation of MSCs from solid tissues,
with no major effects on cellular proliferation, migration or differentiation characteristics. However, higher MSC
yields were achieved in a shorter period of time by collagenase digestion, which is advantageous for the
therapeutic use of MSCs. Moreover, based on the higher level of expression of scleraxis in MSCs isolated by
enzymatic digestion, these cells might be a better choice when attempting tendon regeneration.
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Multipotent mesenchymal stromal cells (MSCs) are de-
scribed as highly proliferative cells with the capacities
of tri-lineage differentiation and plastic adherence [1,2].
These cells are a promising cell population for alternative
treatments of orthopaedic injuries. In equine athletes,
MSCs are frequently applied to treat tendon injuries,
such as core lesions in the superficial digital flexor tendon
(SDFT). Clinical studies have shown more favourable out-
comes for this treatment as compared to conventional
treatment [3-8].
Currently, the most widely used tissue sources for
isolation of MSCs in equine medicine are bone marrow
(BM) and subcutaneous adipose tissue (AT) [6,9,10].
Although recovery of MSCs from BM is common, there
are concerns about the invasive BM aspiration procedure
and the potential complications for donor horses [11,12].
Furthermore, there are cell culture-specific restrictions as-
sociated with MSCs derived from BM, such as early cell
senescence associated with donor age and limited recovery
of MSCs [12-14]. In comparison to BM, various solid tis-
sues, such as AT, tendon tissue or umbilical cord matrix
(UCM) appear to yield higher numbers of MSCs that are
highly proliferative and that also possess tri-lineage differ-
entiation potential [15-18].
For clinical use, reliably repeatable isolation of an ad-
equate number of MSCs is of great importance [19,20].
Different protocols are available for the isolation of MSCs
from solid tissues [9,21]. However, the potential impact of
the choice of protocol on cell yield and characteristics of
equine MSCs has not yet been investigated.
The most frequently used method for isolation of MSCs
from solid tissue is digestion by proteolytic enzymes, such
as collagenase [22-26]. After digestion, the nucleated cell
fraction is released and can be seeded onto plastic culture
dishes, where MSCs adhere and thus can be separated
from the remaining non-adherent cells.
Other studies have described the isolation of MSCs
from solid tissues by a method referred to as the explant
technique [27-29]. For this technique, excised tissue is
cut into small pieces and plated onto plastic culture
dishes. MSCs migrate from the pieces of tissue and adhere
to the plastic surface. This method requires less labour
and is less invasive to the cells. Moreover, it appears to
have less impact on cell viability [28] and might be advan-
tageous due to the initial presence of native tissue and
similar physical environment [30].
Enzymatic digestion may negatively affect cellular
properties, due to the major alteration of the natural en-
vironment of the cells [30], considering that differences
in culture conditions also cause alterations of MSC
properties [31-33]. However, the impact of differences in
the isolation method on MSC characteristics is not yet
completely understood [15,19,28,34,35].In this study, we isolated MSCs from equine solid tis-
sues by enzymatic digestion or by explant technique. We
subsequently compared cell yield, proliferation, migra-
tion and differentiation potential of the isolated cells, as
well as tendon marker expression, in order to investigate
the influence of the isolation technique on characteris-
tics of isolated equine MSCs. For this purpose, we used
three types of solid tissues as cell sources for the experi-
ments (AT, SDFT and UCM). All three of these tissues
are of different density and stiffness and are known to
host MSCs.Methods
Tissue collection
Equine AT, SDFT and UCM were used as tissue sources
for MSC isolation. Subcutaneous AT and SDFT, respect-
ively, were harvested from eight adult horses (mean age:
3.5 years, interquartile range (IQR): 1.75) following eu-
thanasia. UCM samples were collected from 14 foals
immediately after birth. Sampling procedures followed
the applicable regulations of animal welfare and were
approved by the local ethics committee (Landesdirektion
Leipzig, A 13/10).
For subcutaneous AT collection, the paraxial caudodor-
sal gluteal region was clipped and the skin was aseptically
prepared. An incision of approximately 10 cm length was
made in the skin, and approximately 15 g of subcutaneous
AT was obtained with a scalpel and forceps. The tissue
was processed immediately.
Tendon samples were obtained from the SDFT of one
forelimb of each horse. The palmar region between carpus
and fetlock was clipped and the skin was aseptically pre-
pared. After a skin incision of approximately 10 cm length
was made, about 15 g of tendon tissue was recovered with
a scalpel and forceps and processed immediately.
For UCM collection, approximately 15 cm of the
umbilical cord was recovered immediately after foal
birth. Umbilical cord tissue was washed with povidone-
iodine solution (Braun, Melsungen, Germany) and 70%
ethanol (apomix, Halle/Salle, Germany) for disinfection.
The umbilical cord was placed in a sterile container with
150 ml phosphate-buffered saline (PBS; PAA, Cölbe,
Germany), 0.1% gentamicin (PAA) and 2.5 μg/ml ampho-
tericin B (Life Technologies GmbH, Darmstadt, Germany)
and stored overnight at room temperature.Tissue preparation and cell isolation
Following tissue recovery, the samples were processed
under sterile conditions. Blood vessels were dissected
from UCM samples prior to further preparation.
Equal amounts, of approximately 6 g, of each specimen
were subjected to cell isolation either by tissue digestion
or by explant technique.
Figure 1 Explant technique. Single cells (white arrows) migrated
from the margin of the tissue piece (tendon) and adhered onto the
plastic surface to form cell colonies. Following several days in
culture, cells developed typical spindle-shaped morphology.
Scale bar = 100 μm.
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into pieces of 0.1-0.2 cm size and washed with Hank’s
balanced salt solution (HBSS; Life Technologies GmbH).
Subsequently, the minced tissue pieces were placed in
plastic tubes (BD, Bioscience, Heidelberg, Germany) con-
taining HBSS and collagenase I (Life Technologies GmbH,
catalogue number 17100017) and were incubated at 37°C
in a continuously shaking water bath. AT was digested for
4 hours in a collagenase I solution at a concentration of
0.8 mg/ml. SDFT was digested for 6 hours at a collagenase
concentration of 5.6 mg/ml. UCM was digested for 6 hours
at a collagenase concentration of 2.4 mg/ml. After incu-
bation in collagenase solution, remaining tissue pieces
were discarded. The digestion solution was filtered with
a cell filter (pore size 70 μM; BD Bioscience). The
mononuclear cell (MNC) fraction obtained was sub-
jected to two cycles of centrifugation (437 g, 5 min, 4°C)
and washing in PBS. Subsequently, MNCs were counted
using a microscope counting chamber. The cell pellet
was resuspended in standard cell culture medium con-
sisting of low glucose (1 g/l) Dulbecco’s Modified Eagle
Medium (DMEM; Life Technologies GmbH) supple-
mented with 20% foetal calf serum (FCS; Sigma-Aldrich,
Hamburg, Germany, catalogue number F7524), 0.1%
gentamicin, and 1% penicillin-streptomycin (PAA). UCM
cell culture medium was additionally supplemented with
0.5 μg/ml amphotericin B until first passage to prevent
fungal contamination of the cultures [14]. MNCs were
seeded onto plastic culture dishes (BD Bioscience) at a
density of approximately 20,000 cells/cm2. Primary cul-
tures (passage [P] 0) were cultivated under standard cul-
ture conditions, i.e. humidified atmosphere at 37°C and
5% CO2, and the culture medium was changed twice a
week. MSCs obtained by digestion, hereafter referred to as
“di-MSCs,” were passaged by trypsinisation (Trypsin, Life
Technologies GmbH) when the cell colonies reached
confluency.
For the isolation of MSCs by explant technique, solid
tissues were dissected into pieces of approximately 0.5 ×
0.5 × 0.5 cm size using a surgical blade and forceps and
then washed in PBS. Tissue pieces were placed onto cell
culture dishes (TPP, Trasadingen, Switzerland) and cov-
ered with standard cell culture medium to allow cell mi-
gration from the tissue pieces onto the culture plate
(Figure 1). Culture conditions were identical to those
following enzymatic digestion. After 7 days, tissue pieces
were carefully removed. Primary cultures (P0) were pas-
saged at confluency of colonies to obtain MSCs isolated
by explant technique, hereafter referred to as “ex-MSCs”.
In the subsequent assays, di-MSCs and ex-MSCs were
compared separately for each tissue type to assess the
potential effects of the two different isolation techniques.
For these assays, seven paired di- and ex-MSC samples
derived from adipose and tendon tissue, respectively,were used. Due to a partial contamination of UCM sam-
ples, 10 unpaired di- and ex-MSC samples derived from
UCM were available for the following assays.
MSC yield
The number of MSCs was counted following trypsinisa-
tion at the first cell harvest at confluency of colonies. The
yield of MSCs per gram of tissue per primary culture days
was calculated according to the following formula;
MSC yield ¼ cell number at first cell harvest
tissue weight½   number of primary culture days½  :
Proliferation assays
From P1 to P7, cells were plated in culture flasks (BD
Bioscience) at a density of 3,000 MSCs/cm2 and incu-
bated to subconfluency in standard cell culture medium
under standard culture conditions. Subsequently, MSCs
were trypsinised, cell numbers were determined and cells
were subjected to seeding as described above. Generation
times (GTs) were calculated separately for each passage
based on cell counts and culture time according to the fol-
lowing formula:
GT ¼ cell culture time
population doubling
Population doubling ¼
ln cell number at harvestcell number at plating
 
ln2
Cell proliferation was additionally assessed in P3,
as well as in P8, by determining the relative increase
in the number of metabolically active cells using a
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2-(4-sulfophenyl)-2H-tetrazolium (MTS) proliferation
assay, performed according to the manufacturer’s in-
structions. Briefly, 1,000 MSCs per well were seeded
onto a 96-well plate and incubated under standard
culture conditions. At day 1 CellTiter 96® AQueous One
Solution Reagent (Promega, Mannheim, Germany) was
added to the medium and samples were incubated at
37°C, 5% CO2 for 4 hours. Subsequently, the absorb-
ance at 490 nm was measured using Tecan Safire™
(Magellan™ Software; Tecan Group Ltd., Maennedorf,
Switzerland). The same steps were performed in an-
other assay at day 7 after seeding. Proliferation rates
(PRs) were calculated using the following formula:
PR ¼ mean optical density at day 7
mean optical density at day 1
:
Migration potential
The migration potential of MSCs was determined in P3
by spheroid culture. 5,000 cells per spheroid were culti-
vated in hanging drops using non-adherent dishes
(Greiner Bio-One GmbH, Frickenhausen, Germany)
and standard cell culture medium supplemented with
methylcellulose (Sigma-Aldrich) (Figure 2a). After 24 hours,
spheroids were harvested by rinsing with PBS. The
spheroids obtained were plated in standard cell culture
medium on adherent 6-well plates (BD Bioscience) and
incubated under standard culture conditions to allow
the MSCs to migrate out of the spheroids (Figure 2b,c).
Photographs (IX51 research microscope; CC-12 digital
colour camera; Cell^A software; Olympus Soft Imaging
Solutions GmbH, Muenster, Germany) of spheroids and
migrating MSCs were taken after 24 hours of incubation
(Figure 2d). The migration area was determined follow-
ing measurement of spheroid size and the area covered
by MSCs.
migration area ¼ area covered by MSCsð Þ– spheroid sizeð ÞFigure 2 Migration assay. (a) Culture of MSCs using a spheroid system. (
migration 24 hours after spheroid seeding. (d) At the 24 hour time point, t
of the maximum range of migrated MSCs (area A). Scale bar = 200 μm. (MSIn vitro differentiation assays
Adipogenesis assay
1,500 cells/cm2 in P3 were plated onto adherent 12-well
plates (BD Bioscience) in standard cell culture medium to
allow cell attachment. After 3 days, adipogenic differenti-
ation was induced by replacement of culture medium with
adipogenic differentiation medium consisting of DMEM
F-12 (PAA), 15% rabbit serum, 1 μM dexamethasone,
100 μM indomethacin, 500 μM 3-isobutyl-1-methylxan-
thine, 700 nM bovine insulin (all Sigma-Aldrich) and anti-
biotics (0.1% gentamicin, 1% penicillin-streptomycin),
which had been evaluated previously [36]. After 3 days of
incubation, MSCs were fixed with 50% ethanol (Roth,
Karlsruhe, Germany) and stored at −20°C until further
processing. Cell staining was performed with oil red O
solution (Sigma-Aldrich). Two random photographs (IX51
research microscope; CC-12 digital colour camera;
Cell^A software) of each well were evaluated by two
blinded observers using a scoring system based on the
percentage of differentiated cells and the size of intra-
cellular lipid vacuoles (Table 1).
Osteogenesis assay
500 cells/cm2 in P3 were plated onto adherent 12-well
plates in standard cell culture medium. After 3 days of
cell attachment, the culture medium was removed and
cells were incubated with osteogenic differentiation
medium consisting of DMEM F-12, 10% FCS, 0.1 mM L-
ascorbate-2-phosphate, 0.1 μM dexamethasone, 10 mM
β-glycerophosphate (all Sigma-Aldrich) and antibiotics
(0.1% gentamicin, 1% penicillin-streptomycin). Follow-
ing incubation for 21 and 35 days, cells were fixed with
4% paraformaldehyde (Roth) and stored at −20°C until
further processing. For detection of osteogenic differenti-
ation, we used von Kossa staining of extracellular calcium-
deposits. Samples with qualitative evidence of differenti-
ation were further assessed as previously described [37].
Briefly, absorbance at 492 nm was determined for stained
differentiated samples and undifferentiated controls (Tecan
Safire™, Magellan™ Software). Osteogenic differentiation atb) Attachment of spheroid 4 hours after seeding (c) and MSC
he spheroid size was measured (area B) and subtracted from the area
Cs: multipotent mesenchymal stromal cells).
Table 1 Semiquantitative adipogenic differentiation score
% of differentiated cells among all
MSCs in field of view (10× magnification)
Size and arrangement of lipid droplets
0 points 0 – 5% 0 points No lipid droplets
1 point >5 – 50% 1 point Predominantly few isolated and small-sized
(< 1/3 of nucleus diameter) lipid droplets
2 points >50 – 80% 2 points Predominantly medium-sized (approximately 1/3 of nucleus diameter)
lipid droplets, surrounding the nucleus
3 points >80 - 100% 3 points Predominantly large-sized (> 1/3 of nucleus diameter) lipid droplets,
merging around the nucleus
Two criteria scoring system for semiquantitative evaluation of adipogenic differentiation following the oil red O staining procedure. A maximum score of 6 points
was possible, with a maximum of 3 points for each criterion.
Table 2 Gene primer sequences used for qPCR
Gene Primer sequence Amplicon size
GAPDH F: CCAGAACATCATCCCTGCTT 158
NM_001163856 R: CGTATTTGGCAGCTTTCTCC
Collagen 1A2 F: GAAGATGGTCACCCTGGAAA 177
XM_001492939 R: AGGTTCACCCTTCACACCTG
Scleraxis F: ACAGAAAGACGGCGATTCGGAGTT 207
NM_001105150 R: AAAGTTCCAGTGGGTCTGGGCAA
List of genes analysed by real-time quantitative PCR. GenBank accession
numbers of the sequences used for primer design with Primer3 free online
software as well as primer sequences and length of the amplicons in base
pairs are shown. The sequences of primers of the gene scleraxis were kindly
provided by the Institute of Anatomy, University of Veterinary Medicine,
Foundation, Hannover, Germany. (F: forward, R: reverse).
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differentiation (IOD):
IOD ¼ optical density of differentiated samples
optical density of controls
Chondrogenesis assay
Chondrogenic differentiation of P3 MSCs was per-
formed in a 3D-pellet culture system. To obtain stable
3D-cell pellets, 500,000 cells per assay were placed into
a 15 ml polypropylene centrifuge tube (BD Bioscience)
and centrifuged for 5 minutes at 240 g. The cell pellets
were incubated under standard culture conditions with
chondrogenic differentiation medium consisting of high
glucose DMEM (4.5 g/l; PAA), 10 ng/ml TGF-β (Acris
Antibodies, Herford, Germany), 1% ITS + premix (BD
Bioscience), 100 μM L-ascorbate-2-phosphate, 100 nM
dexamethasone (both Sigma-Aldrich), 400 nM proline
(Roth) and antibiotics (0.1% gentamicin, 1% penicillin-
streptomycin). Pellet culture was terminated after 21 days
by fixation with 4% paraformaldehyde. Subsequently, the
pellets were embedded in paraffin and 6 μm paraffin sec-
tions were prepared for Alcian Blue, Masson’s Trichrome
and Safranin O staining. Pellets showing qualitative evi-
dence of chondrogenic differentiation by Alcian Blue and
Masson’s Trichrome staining were then semiquantitatively
evaluated using the Bern Score [38] based on the Safranin
O staining.
Gene expression analysis of tendon markers
Total RNA was isolated from MSC monolayer cultures
(P3) using the RNeasy Mini Kit with On-Column DNase
digestion (both Qiagen, Hilden, Germany). All steps were
performed according to the manufacturer’s instructions.
RNA was quantified (NanoDrop 1000 Spectrophotometer;
NanoDrop Software; Thermo Fisher Scientific, Wilming-
ton, DE, USA) and 1,000 ng of RNA was converted to first
strand cDNA with Omniscript Reverse Transcriptase
(Qiagen). Fluorescence-based real-time quantitative PCR
(qPCR) was performed and monitored using a 7500 Real-Time PCR System (Applied Biosystems, Darmstadt,
Germany). Targeted genes included the tendon markers
collagen 1A2 and scleraxis. Each cDNA sample was mixed
with iQ SYBR Green Supermix (Bio-Rad Laboratories,
Munich, Germany) and gene-specific forward and reverse
primers (primer details are shown in Table 2), and the
threshold cycle was determined for each sample. Cycling
conditions were 40 cycles of denaturation (90°C for
30 sec), annealing (60°C for 30 sec) and elongation (72°C
for 30 sec). A set of negative controls was processed in the
same manner except that cDNA was replaced with water.
The relative copy numbers of target genes were calculated
from the standard curve for each gene and normalised
to the housekeeping gene, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Statistical analysis
The data were processed using PASW Statistics 18 (IBM
Deutschland GmbH, Ehningen, Germany). Comparisons
were made between di-MSCs and ex-MSCs, for each tis-
sue type separately. The Wilcoxon signed-rank test was
used for MSCs derived from AT and from SDFT. Com-
parison of di-MSCs and ex-MSCs derived from UCM was
performed with the Mann–Whitney U test. Significance
was set at a value of p ≤ 0.05. Data were reported as me-
dian (IQR). Outliers were included in the data analysis.
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3.0 times and extreme outliers are any data values that lie
more than 3.0 times the IQR below the first quartile or
above the third quartile.
Results
MSC yield
MSCs were successfully obtained from all three tissues
(AT, SDFT and UCM) using both methods, enzymatic
digestion and explant technique.
The MSC yield per tissue gram per day, following pri-
mary culture was significantly higher using the digestion
method in all tissues (Table 3). Furthermore, ex-MSCs
required significantly more days in primary culture until
the first cell harvest was possible.
Proliferation assays
There were no significant differences in proliferation be-
tween di-MSCs and ex-MSCs (p > 0.05). However, we did
observe trends in proliferation that were dependent on the
respective tissue source.
Ex-MSCs derived from AT and SDFT had lower GTs
in comparison to the respective di-MSCs (Figure 3a and
Figure 3b), indicating faster PRs of ex-MSCs from these
tissues. In contrast, ex-MSCs derived from UCM had
higher GTs than the respective di-MSCs in most passages
(Figure 3c), indicating that in UCM tissue, di-MSCs prolif-
erated faster.
The results from the MTS proliferation assay supported
these findings in MSCs from AT and UCM, as higher PRs
were found in ex-MSCs from AT and lower PRs in ex-Table 3 MSC yield per gram per days for each tissue type
di-MSC
Days in primary culture 6 (2)
MSC yield per gram 21.13 × 105 (18.00 × 105
MSC yield per gram per days 352.2 × 103 (180.9 × 103
di-MSC
Days in primary culture 7 (2)
MSC yield per gram 17.49 × 105 (10.72 × 105
MSC yield per gram per days 291.5 × 103 (176.4 × 103
di-MSC
Days in primary culture 10 (4.25)
MSC yield per gram 4.16 × 105 (12.66 × 105
MSC yield per gram per days 61.7 × 103 (134.2 × 103
Data are presented as median (IQR).
(AT-MSC: adipose tissue-derived MSC; di-MSC: MSC isolated by digestion method; e
MSC: multipotent mesenchymal stromal cell; SDFT-MSC: tendon-derived MSC; UCM
*Indicates significance with a p-value ≤ 0.05.MSCs from UCM, in early as well as late passages
(Figure 4a and Figure 4c). However, the finding that
ex-MSCs derived from SDFT proliferated faster than the
di-MSCs could not be confirmed by the MTS assay, in
which di-MSCs displayed higher PRs (Figure 4b).
Migration potential
Di-MSCs showed a higher migration potential in com-
parison to the corresponding ex-MSC samples, regard-
less of the tissue type (Table 4). However, this difference
was not significant.
In vitro differentiation assays
Successful induction of adipogenic differentiation was
observed in all MSC samples (Figure 5). No distinct dif-
ferences in the adipogenic differentiation scores were
noted between di-MSCs and ex-MSCs, suggesting a
similar adipogenic differentiation potential (Table 4).
Extracellular calcium deposits, indicating successful
osteogenic differentiation, were observed following von
Kossa staining after 21 and 35 days of incubation in all
MSC samples derived from AT and SDFT (Figure 6). In
di-MSCs and ex-MSCs derived from UCM, one sample
in each case did not stain positive for osteogenic differ-
entiation after 21 days of incubation. Following the lon-
ger incubation time of 35 days, all UCM-derived ex-
MSC samples showed positive von Kossa staining, but
one UCM-derived di-MSC sample remained negative.
Table 4 provides a summary of IODs of MSCs, measured
according to the method of Ostanin et al. (2008) [37].
Interestingly, the IOD for UCM-derived ex-MSCs wasAT-MSC
ex-MSC
11 (5) *
) 0.79 × 105 (1.36 × 105) *




) 1.62 × 105 (2.05 × 105) *




) 0.70 × 105 (0.66 × 105) *
) 4.2 × 103 (4.1 × 103) *
x-MSC: MSC isolated by explant technique; IQR: interquartile range;
-MSC: umbilical cord matrix-derived MSC).
Figure 3 Generation times of MSCs from passages 1 to 7 for each tissue type. Circle indicates mild outlier; asterisk indicates extreme outlier.
No significant differences were observed between di-MSCs and ex-MSCs for each tissue type (p-values > 0.05). Generation time = (cell culture
time)/(population doubling). (a) (AT-MSC: adipose tissue-derived MSC; MSC: multipotent mesenchymal stromal cell; (b) SDFT-MSC: tendon-derived
MSC; (c) UCM-MSC: umbilical cord matrix-derived MSC).
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at 21 days of incubation.
In terms of chondrogenic differentiation, all ex-MSCs,
regardless of the tissue type, were positive for glycosami-
noglycans and collagen, as demonstrated by Alcian Blue
and Masson’s Trichrome staining (Figure 7). Furthermore,
all di-MSC samples derived from UCM were able to dif-
ferentiate towards the chondrogenic lineage. In the case of
the di-MSCs derived from AT and SDFT, not all samples
showed evidence of chondrogenesis. Two samples from
AT and one sample from SDFT did not stain positive for
glycosaminoglycans and collagen. Cell pellets that showed
successful chondrogenic differentiation, as confirmed by
positive Alcian Blue and Masson’s Trichrome staining,
were further evaluated using the Bern Score [38] following
Safranin O staining (Figure 7). No significant differences
were observed between di-MSCs and ex-MSCs (Table 4).
Di-MSCs and their corresponding ex-MSCs derived from
AT and UCM were assigned similar score points. Ex-Figure 4 Proliferation rates of MSCs (passages 3 and 8) for each tissu
observed between di-MSCs and ex-MSCs for each tissue type (p-values > 0.
chymal stromal cell; (b) SDFT-MSC: tendon-derived MSC; (c) UCM-MSC: umMSCs derived from SDFT tended to have slightly higher
scores compared to their corresponding di-MSCs.
Gene expression analysis of tendon markers
A trend towards higher expression of collagen 1A2 was
observed in di-MSCs derived from AT and SDFT, in
comparison to the corresponding ex-MSCs. In contrast,
di-MSCs derived from UCM displayed a trend towards
lower gene expression of collagen 1A2, in comparison to
their corresponding ex-MSCs (Figure 8a). Di-MSCs
showed higher gene expression levels of the tendon
marker scleraxis in comparison to ex-MSCs, regardless of
the tissue type (Figure 8b). In MSCs derived from SDFT
and UCM, the differences were significant, with p-values
of 0.047 and 0.038, respectively.
Discussion
In this study, MSCs were successfully isolated from equine
AT, UCM and SDFT by tissue digestion and by explante type. Circle indicates mild outlier. No significant differences were
05). (a) (AT-MSC: adipose tissue-derived MSC; MSC: multipotent mesen-
bilical cord matrix-derived MSC).
Table 4 Migration and differentiation potential of MSCs
AT-MSC
di-MSC ex-MSC
Migration area [mm2] 0.237 (0.033) 0.207 (0.384)
Adipogenic differentiation score 5.5 (0.0) 5.5 (0.5)
IOD (day 21) 2.2418 (0.6207) 2.0118 (1.5715)
IOD (day 35) 3.7193 (1.5035) 4.8596 (3.3090)
Chondrogenic differentiation score 2.5 (0.75) 3.0 (0.5)
SDFT-MSC
di-MSC ex-MSC
Migration area [mm2] 0.353 (0.213) 0.238 (0.126)
Adipogenic differentiation score 5.5 (0.0) 5.5 (0.0)
IOD (day 21) 2.8386 (1.2352) 3.0644 (1.7268)
IOD (day 35) 4.2629 (1.4771) 3.7185 (1.8768)
Chondrogenic differentiation score 1.875 (2.75) 3.5 (2.5)
UCM-MSC
di-MSC ex-MSC
Migration area [mm2] 0.090 (0.124) 0.048 (0.128)
Adipogenic differentiation score 4.5 (1.0) 4.25 (0.75)
IOD (day 21) 1.0211 (0.2223) 1.1055 (0.2843)
IOD (day 35) 1.2135 (0.2767) 0.9519 (0.0800)
Chondrogenic differentiation score 3.5 (1.5) 3.0 (2.75)
Data are presented as median (IQR).
(AT-MSC: adipose tissue-derived MSC; di-MSC: MSC isolated by digestion
method; ex-MSC: MSC isolated by explant technique; IOD: index of osteogenic
differentiation; IQR: interquartile range; MSC: multipotent mesenchymal
stromal cell; SDFT-MSC: tendon-derived MSC; UCM-MSC: umbilical cord matrix-
derived MSC).
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differentiation behaviour of isolated MSCs was performed
for comparative evaluation of both MSC isolation methods.
Interestingly, no major differences between cellular
properties of di-MSCs and ex-MSCs were observed in
the current study, with the exception of a higher level of
expression of scleraxis in di-MSCs. However, the tissueFigure 5 Adipogenic differentiation. Adipogenic differentiation demons
red O, shown for MSCs derived from tendon tissue (at 3 days of incubation
technique. Scale bar = 200 μm. (MSC: multipotent mesenchymal stromal cedigestion method yielded significantly more MSCs in a
shorter period of time.
For this study, horses were chosen as donor animals,
as the treatment of orthopaedic injuries with MSCs is
currently a widely used treatment in equine medicine
[3-5]. Furthermore, due to pathophysiological similarities
between human and equine orthopaedic diseases, the
horse is an appropriate model for orthopaedic research
in human medicine [39].
Three different solid tissues, AT, SDFT and UCM,
were chosen for exemplary evaluation of MSC isolation
methods. These tissues were considered suitable as they
were already known to host MSCs [15,16,18] and also
because their different densities and stiffness allowed for
evaluation of protocols under different conditions.
Different techniques exist for isolation of MSCs from
diverse sources. In this study, both a standard tissue di-
gestion using collagenase and MSC isolation by explant
technique were performed. Enzymatic digestion by colla-
genase, first described by Rodbell (1964) [40], is a widely
used method for degradation of the collagen network of
solid tissue. Nonetheless, some studies have described
disadvantages to this method, such as the relatively high
costs of reagents, time-consuming labour and inconsist-
ent results due to heterogeneous preparations of pure
collagenase solutions [41-44]. To avoid the latter, a uni-
form batch of collagenase has been used in this study.
Previous studies have investigated other enzymatic
methods for MSC isolation, such as the use of liberase,
trypsin and hyaluronidase, in order to achieve a repro-
ducible and qualitatively improved tissue digestion and
avoid damage to the isolated cells, as an alternative to
crude collagenase digestion [20,41,45,46]. However, the
use of these alternative enzymatic methods is not with-
out controversy [47]. Therefore, in the present study,
standard enzymatic digestion using collagenase was per-
formed for the comparison of MSC isolation tech-
niques. In order to achieve the mildest enzymatictrated by the accumulation of intracellular lipid droplets stained by oil
). (a) MSCs isolated by digestion. (b) MSCs isolated by explant
ll).
Figure 6 Osteogenic differentiation. Osteogenic differentiation with deposition of extracellular calcium visualized by von Kossa staining, shown
for MSCs derived from adipose tissue (top: 21 days of incubation; bottom: 35 days of incubation). (a) MSCs isolated by digestion. (b) MSCs
isolated by explant technique. Scale bar = 200 μm. (MSC: multipotent mesenchymal stromal cell).
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were adapted to the requirements of the tissues used as
MSC sources, which had been evaluated earlier (unpub-
lished data), as previously suggested by others [30,47-49].
Several studies have reported the effects of enzymes,
endotoxin and chemotactic tissue breakdown products
on the phenotype and behaviour of cells [30,41,47,50, 51].
Therefore, we considered a non-enzymatic isolation tech-
nique to recover MSCs, which would potentially be less
affected and damaged than by an enzymatic isolation
technique [28,52,53]. In this study, the isolation of MSCs
by explant technique was performed and compared to
collagenase digestion. The obvious benefit of this non-
enzymatic cell isolation technique is that the procedure
is simpler in comparison to the enzymatic method and
does not require expensive enzymes.
We hypothesized that collagenase digestion affects
the isolated cells, while the explant technique does not,
thus resulting in differences between the cellular prop-
erties of di-MSCs and ex-MSCs. However, this hypoth-
esis was not supported by the present study, as no
major differences were found regarding most cellular
properties investigated here.
The most important difference between the two MSC
isolation techniques was that collagenase digestion yielded
significantly more MSCs than the explant technique,
which is consistent with published data [28,44,47]. Apossible explanation might be that only cells located at
the tissue margin can migrate out of the tissue in the
explant technique, so that not all MSCs residing in the
tissue can be collected when using this technique. A
practical option to improve the MSC yield from explant
cultures might be to minimize the size of the tissue
samples. The MSC numbers per gram of tissue that
were obtained by each isolation method in this study
are within a similar range to MSC yields reported in
other studies [21,28]. Despite significant differences
between cell yields, which might suggest differences
between the isolated cell populations, di-MSCs and ex-
MSCs displayed similar characteristics during further
analyses.
Variation in isolation protocols, as well as alteration of
culture conditions, have been reported to influence pro-
liferation of MSCs [31,32,34]. This could be due to the
fact that some extrinsic substances may be toxic and in-
duce cell death [31,32] and, therefore, cause variation in
viability and expansion potential. In the present study,
di-MSCs required less time for primary cultivation in
comparison to ex-MSCs. It is likely that this effect was
due to the fact that digestion initially makes more cells
accessible, rather than to differences in proliferation po-
tential of di-MSCs. In all subsequent passages, when the
initial seeding density was standardised, proliferation of
di-MSCs and ex-MSCs was similar.
Figure 7 Chondrogenic differentiation. Chondrogenic differentiation demonstrated by the presence of glycosaminoglycans and collagen. (top)
Alcian Blue, (middle) Masson’s Trichrome and (bottom) Safranin O staining in MSCs derived from umbilical cord matrix after 21 days of incubation.
(a) MSCs isolated by digestion. (b) MSCs isolated by explant technique. Scale bar = 200 μm. (MSC: multipotent mesenchymal stromal cell).
Figure 8 Expression levels of (a) collagen 1A2 (Col1A2) and (b) scleraxis (Scx). Star indicates extreme outlier. (AT-MSC: adipose tissue-
derived MSC; MSC: multipotent mesenchymal stromal cell; SDFT-MSC: tendon-derived MSC; UCM-MSC: umbilical cord matrix-derived MSC).
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http://www.biomedcentral.com/1746-6148/9/221Migration potential of MSCs is considered important
for their integration into the host tissue during thera-
peutic applications. Several studies have reported inhib-
ition or increase of migration capacity by different drugs
in vitro [31,54,55]. Furthermore, a comparative study
of different protocols for isolation of BM-MSCs also
showed that isolation conditions affect migration ability
[34]. Similarly, the technique used to isolate MSCs may
affect the ability of MSCs to migrate from solid tissues. In
the present study, di-MSCs derived from all the tissues
studied, showed a trend towards increased migration
activity in comparison to ex-MSCs. This finding was
surprising, given that the ex-MSCs had initially been
selected based on their migratory capacity during the
isolation procedure. Further studies to investigate these
effects are necessary. Furthermore, the cultivation of MSCs
in a 3D-spheroid assay may be advantageous for injection
of MSCs. The investigation of migration potential in these
spheroids could potentially be used to assess the ability of
the applied MSCs to leave the spheroids and migrate into
surrounding host tissue.
In this study, no significant differences were observed
in the adipogenic, osteogenic or chondrogenic differenti-
ation capacity between di-MSCs and ex-MSCs. This
finding is consistent with results of previous studies in
which different methods for isolation of MSCs were
compared [28,34]. In contrast, several studies have dem-
onstrated that changes in culture conditions or cultiva-
tion alone seem to affect cellular properties such as the
differentiation potential [31,51,56]. Due to standardised
and optimised differentiation conditions, such influences
on differentiation potential were avoided in the present
study.
Analyses of osteogenic and chondrogenic differenti-
ation were performed using standard protocols described
in the literature [57]. The observed decrease in IOD for
UCM-derived ex-MSCs following longer incubation
could be due to partial cell detachment during the lon-
ger cultivation time.
The adipogenic differentiation protocol was modified
based on an evaluation of different protocols for equine
MSCs [36], as insufficient adipogenic differentiation of
equine MSCs has been repeatedly reported after stand-
ard induction [26,58]. The modification of the protocol
included supplementation of adipogenic differentiation
medium with rabbit serum, of which the benefit for
adipogenic differentiation has been previously de-
scribed [26,36,58].
Significantly higher expression levels of the tendon
phenotype-related gene scleraxis [59-62], were found in
MSCs isolated by enzymatic digestion. Alterations in
expression levels of other target genes following the di-
gestion technique have been shown in several studies
[51,56,63]. Potentially, these alterations are caused bythe altered environmental conditions the cells are sub-
jected to during enzymatic tissue digestion. It could be
also hypothesised that collagen breakdown products
from the digested tissues trigger upregulation of the
scleraxis gene. There were no noticeable differences in
expression levels of collagen 1A2, one of the key com-
ponents of tendon matrix [64,65], between di-MSCs
and ex-MSCs. It is possible that collagen expression is
more stable to influence by extrinsic factors. This hypoth-
esis is supported by published data showing that no varia-
tions in transcription level of collagen were observed
following supplementation of cell culture medium with
ibuprofen [33]. However, only the expression of collagen
1A2 was investigated in present study. During tendon
degeneration, initially there is an increased level of
collagen 3 fibers which are probably only later replaced
by collagen 1 fibers [65]. Hypothesising that collagen
breakdown products produced during tissue digestion
simulate the early phase of healing and thus stimulate
upregulation of tendon markers, collagen 3 expression
might be upregulated rather than collagen 1 expression.
Still, whether a higher expression of tendon markers
in vitro reflects the situation in vivo and is a reliable in-
dicator of the effect of MSCs on tendon healing remains
to be evaluated.
The cell population harvested by enzymatic digestion is
potentially heterogeneous, and this raises the question as
to whether the isolated cells are in fact MSCs. Further
evaluation of cellular properties is important to determine
whether these cells represent tissue specific cells, such as
tenocytes, or display characteristics of MSCs [33,59,64].
Cells isolated in this study were identified as MSCs
based on their capacities for self-renewal, plastic-
adherence and tri-lineage differentiation. These char-
acteristics are regarded as minimal, but adequate, criteria
for identification of MSCs [26,34,66].
Evaluation of expression of specific stem markers would
have provided more accurate information. However, in
contrast to human cells, an established set of equine
MSC-specific cell surface markers is not yet available due
to the limited reactivity of available antibodies with equine
epitopes [67,68].
Despite the lack of evaluation of MSC markers, the re-
sults of this study show that the isolation method has
no major influence on cellular growth and tri-lineage
differentiation characteristics. Furthermore, no negative
effects of collagenase digestion on the isolated cells
were observed. Our results are in accordance with the
suggestion that alterations in experimental conditions
are of minor importance to cell behaviour in compari-
son to cell source and interdonor variability [20]. Never-
theless, optimisation and standardisation of isolation
protocols are required in order to improve comparabil-
ity of results obtained in different studies [21,35].
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Collagenase digestion and the explant method are both
feasible and effective techniques for isolation of MSCs
from solid tissues. In this study, the MSCs obtained via
both methods displayed similar growth characteristics
and tri-lineage differentiation capacities. However, isola-
tion of MSCs from solid tissues by digestion appears
advantageous for therapeutic use due to the higher ob-
tainable MSC yields with less time in primary culture.
Furthermore, the higher gene expression levels of scler-
axis in di-MSCs suggest a potentially more effective role
for these cells in tendon regeneration. Further investiga-
tion to confirm this hypothesis is required.
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